# Comparative Zoonotic Disease Surveillance: Wildlife, Livestock, and Human Health Interfaces


## Key Takeaways

- Zoonotic disease surveillance across wildlife, livestock, and human health sectors is fundamentally shaped by distinct objectives, legal mandates, and operational capacities, necessitating careful consideration of these differences for effective cross-sectoral integration. Livestock surveillance prioritizes disease control and trade certification using defined populations and standardized, high-throughput diagnostics, while wildlife surveillance focuses on early detection of emerging pathogens with variable sampling and often species-specific diagnostic validation challenges. Human surveillance targets outbreak detection and clinical management, relying on healthcare-seeking behavior and standardized human clinical laboratory assays.

- The One Health framework emphasizes the interdependence of human, animal, and environmental health, advocating for integrated surveillance systems to detect zoonotic threats early. However, practical integration is hindered by differing data standards, governance structures, and sampling frames; for instance, livestock surveillance often uses individual animal or herd-level data with standardized identifiers, whereas wildlife surveillance relies on opportunistic sampling with incomplete demographic information, and human surveillance focuses on case-based reporting with clinical outcomes.

- Diagnostic test selection and interpretation vary significantly across sectors, impacting data comparability. Livestock surveillance balances sensitivity and specificity against economic costs of false positives/negatives for eradication programs, while wildlife surveillance often prioritizes maximizing sensitivity to detect novel pathogens, accepting lower specificity. Human surveillance prioritizes clinical sensitivity, using confirmatory testing to resolve false positives, leading to different cutoffs or predictive values for the same diagnostic test across sectors.

- Operational integration of surveillance data requires harmonization of case definitions, diagnostic protocols, and reporting intervals, as well as agreement on analytical frameworks and decision thresholds. For example, a livestock program might classify a herd as positive based on bulk tank milk ELISA, while a human health system requires culture confirmation for individual cases, highlighting the need for careful accounting of differing sensitivities and specificities in comparative analyses.

- Common failure modes in cross-sectoral surveillance include silent divergence of case definitions, temporal misalignment due to differing reporting intervals (e.g., production cycles vs. near-real-time human reporting), loss of the wildlife component due to funding cuts, and diagnostic drift from laboratory assay changes. Discriminating checks, such as comparing raw data against sector-specific definitions and plotting detection effort alongside detection counts, are crucial for accurate interpretation.

---

Zoonotic disease surveillance operates across three distinct sectors that differ fundamentally in their objectives, legal mandates, sampling frames, diagnostic capacity, and data governance. Veterinary researchers designing or evaluating surveillance systems must understand these differences to interpret findings correctly and to build interoperable systems. This article compares surveillance approaches across wildlife, livestock, and human health sectors, with emphasis on how each sector's institutional logic shapes what is detected, when it is detected, and how the resulting data can be used. The intended reader is a veterinary researcher or graduate student engaged in cross-sectoral surveillance design, outbreak investigation, or One Health research.

The comparison is organized around four axes: surveillance objectives, population sampling and diagnostic methods, data standards and governance, and the practical integration of outputs across sectors. The article draws on published comparisons of national control programs, international standards from the World Organization for Animal Health, and the conceptual framework of the WHO One Health initiative. It does not provide species-specific clinical guidance, which is available in standard veterinary references, but rather the comparative logic that allows a researcher to transfer methods and interpret results across sectors.

## At a Glance

| Parameter | Livestock Surveillance | Wildlife Surveillance | Human Surveillance |
| --- | --- | --- | --- |
| Primary objective | Disease control, eradication, trade certification, production protection | Early detection of emerging pathogens, conservation impact | Outbreak detection, clinical case management, public health intervention |
| Legal basis | Often mandatory, with regulatory authority and enforceable control measures | Variable, frequently passive or project-based, limited regulatory authority | Mandatory for notifiable diseases, with established public health law |
| Sampling frame | Defined populations, accessible, individually identified in many systems | Unstructured populations, convenience sampling, opportunistic carcass submission | Clinical presentations, laboratory-confirmed cases, syndromic reporting |
| Diagnostic platforms | High-throughput, standardized, often accredited laboratories | Variable, species-specific test validation often lacking | Human clinical laboratories, standardized assays, rapid point-of-care tests |
| Data timeliness | Periodic to continuous, with defined reporting intervals | Often delayed, dependent on passive reporting and research cycles | Near-real-time for notifiable conditions, weekly for syndromic systems |
| Primary data users | Producers, veterinary authorities, trading partners | Conservation agencies, research community, public health | Clinicians, public health authorities, policy makers |
| Key limitation | Surveillance bias toward production diseases and trade-relevant pathogens | Detection bias from variable sampling effort and diagnostic sensitivity | Surveillance bias toward clinically apparent disease and healthcare access |

## Conceptual Foundations of Cross-Sectoral Surveillance

The rationale for linking human and animal surveillance rests on the observation that most emerging infectious diseases are zoonotic and that pathogens move across species boundaries through ecological and production-system interfaces. The medical and veterinary communities should work closely together in clinical, public health, and research settings because zoonoses can infect both animals and humans, and because animal surveillance often provides earlier warning than human case detection. This principle, articulated in the institutional literature on confronting zoonoses, underpins the design of integrated surveillance programs for pathogens such as avian influenza virus, West Nile virus, and foodborne bacteria.

The One Health framework formalizes this interdependence. The WHO One Health initiative links human, animal, and environmental health for zoonotic disease and antimicrobial resistance control, and the CDC provides guidance on zoonotic disease prioritization and cross-sector collaboration. These frameworks do not prescribe a single surveillance architecture. Instead, they establish the expectation that surveillance data from each sector should be interpretable in the context of the others, even when collection methods and objectives differ.

### Surveillance Objectives and Their Consequences

Livestock surveillance programs typically pursue eradication, prevalence reduction, or trade-related freedom from infection. These objectives require defined populations, repeated testing, and enforceable control measures. The Danish programs for bovine viral diarrhea, paratuberculosis, and Salmonella Dublin illustrate how objective shapes design: eradication programs for BVDV and Salmonella Dublin were mandatory, used frequent legislative updates, and achieved measurable prevalence reductions, while the paratuberculosis program remained voluntary with different goals. The zoonotic motivation for Salmonella Dublin control was explicit, whereas BVDV and paratuberculosis programs were driven primarily by economic and welfare considerations.

Wildlife surveillance serves different ends. It detects emerging pathogens before they reach livestock or human populations, monitors reservoir dynamics, and assesses conservation impacts. Sampling is constrained by animal accessibility, and diagnostic test validation for wildlife species is frequently incomplete. The vector competence studies for Usutu virus illustrate the research-driven nature of wildlife surveillance: experimental infection of mosquito colonies and wild bird species is required to interpret field detections, and this work proceeds independently of any regulatory surveillance mandate.

Human surveillance is oriented toward clinical case detection, outbreak recognition, and intervention. It captures zoonotic infections only when they produce disease severe enough to prompt healthcare seeking and laboratory confirmation. This creates systematic underdetection of mild or subclinical zoonotic infections, a limitation that must be accounted for when comparing human case counts with animal prevalence data.

## Study Design Logic Across Sectors

Surveillance design choices follow from the objective and the population. Active surveillance applies a defined diagnostic test to a sampled population at specified intervals. Passive surveillance relies on clinical recognition and voluntary reporting. Livestock systems can support active surveillance because animals are identifiable and accessible. Wildlife systems rarely can, so they depend on passive reporting supplemented by targeted research projects. Human systems use both, with mandatory reporting for notifiable diseases and syndromic surveillance for early warning.

The Danish comparison demonstrates that program success depends on matching instruments to objectives. Eradication required mandatory participation, regular testing, and legal enforcement. Surveillance after eradication required a different instrument set, focused on maintaining freedom from infection with lower testing intensity. Voluntary programs achieved different outcomes because they could not compel participation or enforce control measures. These design principles transfer across sectors, but the legal and administrative instruments available in wildlife and human systems differ from those in livestock production.

### Diagnostic Test Selection and Interpretation

Test performance must be interpreted in the context of the target population and the purpose of testing. A test validated for cattle may perform differently in wildlife species, and the protein A/G conjugate ELISA for Toxoplasma gondii detection illustrates the value of multi-host diagnostic platforms. This non-species-specific assay detects IgG antibodies across pigs, cats, mice, and seals, enabling comparative surveys without species-specific conjugate development. The assay showed excellent agreement with host-specific ELISA and Western blot in experimentally infected pigs, supporting its use in large-scale surveys across a broad range of warm-blooded animals.

For livestock surveillance, test sensitivity and specificity must be balanced against the cost of false positives and false negatives in an eradication program. For wildlife surveillance, the priority is often maximizing sensitivity to avoid missing an emerging pathogen, accepting lower specificity. For human surveillance, clinical sensitivity is paramount, and confirmatory testing is used to resolve false positives. These different priorities mean that the same diagnostic test may be used with different cutoffs or interpreted with different predictive values across sectors.

## International Standards and Governance

The World Organization for Animal Health terrestrial code provides international standards for animal health surveillance, welfare, and trade-related disease control. These standards define acceptable surveillance approaches for demonstrating freedom from infection, which is a prerequisite for international trade in animals and animal products. The standards are written primarily for livestock populations and assume a level of population management and veterinary oversight that does not exist in most wildlife systems. Applying WOAH standards to wildlife surveillance requires adaptation, and the resulting data may not satisfy trade requirements even when they provide valuable epidemiological information.

Human surveillance is governed by national public health law and international health regulations, which differ from animal health governance in their enforcement mechanisms and their relationship to trade. The institutional separation of human and animal health governance creates practical barriers to data sharing, even when the scientific case for integration is strong. Researchers designing comparative surveillance systems must address these governance differences explicitly, because they determine whether data can be shared, who has authority to act on findings, and what legal protections apply to surveillance participants.

## Operational Architecture of Cross-Sectoral Surveillance

### Data Standards and Interoperability

Surveillance data generated in wildlife, livestock, and human health sectors differ in format, granularity, and temporal resolution. Livestock surveillance typically operates on individual animal or herd-level records with standardized identifiers, while wildlife surveillance often relies on opportunistic sampling events with incomplete demographic data. Human surveillance systems prioritize case-based reporting with clinical outcomes. These discrepancies create integration failures when data are pooled for cross-sectoral analysis.

The [WHO One Health framework](https://www.who.int/health-topics/one-health) identifies data harmonization as a prerequisite for effective zoonotic disease monitoring. In practice, harmonization requires agreement on case definitions, diagnostic test protocols, and reporting intervals before data collection begins. For example, a Salmonella Dublin surveillance program targeting cattle may classify a herd as positive based on bulk tank milk ELISA results, whereas a human health surveillance system classifies individual cases by culture confirmation. These definitions are not interchangeable, and comparative analyzes must account for the differing sensitivity and specificity of each classification scheme.

The [Danish cattle surveillance programs for BVDV, paratuberculosis, and Salmonella Dublin](https://pubmed.ncbi.nlm.nih.gov/34350228/) illustrate how data standards evolve with program objectives. The BVDV program, which achieved eradication in 2006, transitioned from active control to surveillance by shifting data collection from herd-level testing to risk-based sampling. The Salmonella Dublin program, by contrast, retained mandatory participation and legislative updates to maintain prevalence estimates at the herd level. These programs demonstrate that data standards must be revised as disease status changes, and that surveillance instruments designed for eradication are not necessarily appropriate for post-eradication monitoring.

### Sampling Strategies and Bias

Sampling frames differ fundamentally across sectors. Livestock populations are enumerated, accessible, and subject to regulatory oversight, permitting probability-based sampling designs. Wildlife populations are rarely enumerated, and sampling is constrained by capture feasibility, seasonal movements, and ethical considerations. Human populations are enumerated through census data, but surveillance relies on healthcare-seeking behavior, which introduces selection bias.

Passive surveillance, which depends on clinical case detection and reporting, is the default in most human and companion animal systems. Its sensitivity is limited by the probability that an infected individual seeks care, that the clinician recognizes the condition, and that the case is reported. Active surveillance, in which investigators initiate case detection, is more resource-intensive but yields more reliable prevalence estimates. The [Danish BVDV program](https://pubmed.ncbi.nlm.nih.gov/34350228/) used active surveillance with mandatory testing to achieve eradication, whereas the voluntary paratuberculosis program relied on producer-initiated testing and produced less certain prevalence estimates.

Wildlife surveillance frequently employs convenience sampling of hunter-harvested animals, road-killed specimens, or animals submitted to rehabilitation centers. These samples are biased toward detectable morbidity and may not represent the general population. For vector-borne zoonoses such as Usutu virus, surveillance of mosquito vectors provides an alternative sampling frame that captures transmission risk before clinical cases appear. [Experimental vector competence studies in German Culex pipiens biotype molestus and Culex torrentium](https://pubmed.ncbi.nlm.nih.gov/33380339/) demonstrate that vector surveillance can identify species capable of sustaining transmission, information that clinical surveillance alone cannot provide.

### Laboratory Networks and Diagnostic Harmonization

Comparative surveillance requires diagnostic results that are comparable across laboratories and species. This requirement is complicated by species-specific differences in immune responses and by the availability of validated assays. The [protein A/G conjugate ELISA for Toxoplasma gondii detection](https://pubmed.ncbi.nlm.nih.gov/24365243/) exemplifies a cross-species diagnostic approach: by using a conjugate that binds IgG across multiple mammalian species, the assay eliminates the need for species-specific reagents and permits direct comparison of seroprevalence between pigs, cats, mice, and seals. This approach is particularly valuable in wildlife surveillance, where species-specific reagents are often unavailable.

However, cross-species assays do not eliminate the need for species-specific validation. Sensitivity and specificity estimates derived from experimentally infected pigs may not transfer to free-ranging wildlife, where infection dynamics, co-infections, and sample quality differ. Laboratories participating in multi-sectoral surveillance should establish species-specific validation data and participate in external quality assessment programs.

### Data Integration and Analysis

Integration of surveillance data across sectors requires a common analytical framework. The most common approach is temporal and spatial correlation: comparing incidence trends in livestock, wildlife, and human populations to identify coincident clusters. This approach is descriptive and cannot establish causation, but it generates hypotheses for targeted investigation.

Quantitative integration methods include risk factor analysis, in which sector-specific data are combined in regression models, and transmission dynamic models, which simulate pathogen spread across species. These methods require data on contact rates between species, which are rarely available from routine surveillance. The [comparative functional genomics of bovine macrophage responses to Mycobacterium bovis and Mycobacterium avium subspecies paratuberculosis](https://pubmed.ncbi.nlm.nih.gov/25414700/) illustrates a different integration pathway: molecular data linking pathogen strain characteriztics to host responses can inform surveillance design by identifying which pathogen variants pose the greatest cross-species transmission risk.

### Decision Triggers and Thresholds

Surveillance systems generate data, but data only become actionable when linked to predefined decision thresholds. Thresholds differ by sector and by disease. For livestock diseases with trade implications, thresholds are often set by international standards. The [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) provides notification requirements and trade-related standards that function as de facto surveillance thresholds for WOAH-listed diseases.

For zoonotic diseases without trade implications, thresholds are typically set by public health authorities based on human disease burden. The [CDC One Health resources](https://www.cdc.gov/one-health/index.html) describe a prioritization process that weighs human health impact, economic burden, and intervention feasibility. These priorities do not always align with veterinary priorities, and surveillance programs must explicitly negotiate which sector's thresholds govern decision-making.

### Comparative Surveillance System Characteriztics

The following table compares surveillance system characteriztics across the three sectors and identifies integration points.

| Characteriztic | Wildlife | Livestock | Human |
|---|---|---|---|
| Population enumeration | Incomplete, often unknown | Complete, registered | Complete, census-based |
| Primary sampling frame | Opportunistic, convenience | Probability-based, herd-level | Healthcare-seeking, case-based |
| Diagnostic validation | Species-specific, often lacking | Well-validated, production species | Extensively validated |
| Reporting interval | Event-driven, irregular | Scheduled, regulatory | Case-based, immediate |
| Primary objective | Pathogen detection, conservation | Trade, production, zoonotic risk | Clinical care, outbreak detection |
| Funding source | Research grants, conservation | Producer, government | Government, insurance |
| Integration point | Early warning for novel pathogens | Prevalence estimation, intervention evaluation | Clinical outcome data, outbreak confirmation |
| Key limitation | Detection bias, small samples | Production focus may miss wildlife spillover | Underreporting, healthcare access bias |

### Documentation and Communication Protocols

Surveillance findings must be documented in formats that support cross-sectoral use. Veterinary surveillance reports typically include species, diagnostic test, and geographic location, but may omit the sampling context needed for epidemiological interpretation. Wildlife surveillance reports should specify capture method, animal condition, and sample quality. Human surveillance reports should include exposure history when zoonotic transmission is suspected.

The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides species-specific guidance on specimen collection and diagnostic interpretation that supports standardized documentation across veterinary sectors. [AVMA practice resources](https://www.avma.org/resources-tools) offer additional guidance on reporting obligations and professional communication in zoonotic disease contexts.

Communication protocols should specify which findings are shared across sectors, at what interval, and through which channels. In jurisdictions where veterinary and human health agencies operate under separate legal authorities, formal data-sharing agreements are required before surveillance data can be exchanged. These agreements should specify data ownership, confidentiality protections, and the conditions under which individual-level data may be disclosed.

The [call for integrated medical and veterinary surveillance systems](https://pubmed.ncbi.nlm.nih.gov/16704801/) made by Kahn in 2006 remains relevant: effective zoonotic disease surveillance depends on structured collaboration between human and animal health professionals, also on parallel data collection. The practical expression of this collaboration is a surveillance architecture in which each sector's data are collected with awareness of the other sectors' needs, and in which decision thresholds are negotiated instead of imposed.

## Recognized Complications and Failure Modes

Cross-sectoral surveillance programs fail in characteriztic patterns. The most common is silent divergence of case definitions between sectors. A human clinician counts a laboratory-confirmed infection, a livestock veterinarian counts a seropositive herd, and a wildlife ecologist counts a mortality event. Each sector reports a different numerator for the same outbreak. Detection depends on periodic cross-audit of raw data against each sector's case definition, not on comparing summary statistics.

A second failure mode is temporal misalignment. Livestock surveillance often operates on production cycles, wildlife surveillance on seasonal sampling windows, and human surveillance on continuous reporting. A peak in one sector may be an artefact of sampling intensity instead of transmission. The discriminating check is to plot detection effort alongside detection counts before interpreting trends.

Loss of the wildlife component is a third pattern. When funding tightens, wildlife sampling is usually the first activity cut because it lacks the regulatory mandate that livestock and human surveillance carry. The consequence is delayed detection of spillover events, since wildlife often serves as the amplification host before livestock or human cases appear. The Danish cattle programs for bovine viral diarrhea and Salmonella Dublin illustrate how mandatory participation and frequent legislative updates sustain livestock surveillance, whereas voluntary programs such as the paratuberculosis scheme show slower progress and weaker compliance [Nielsen et al., comparative review of Danish cattle surveillance programs](https://pubmed.ncbi.nlm.nih.gov/34350228/).

A fourth failure mode is diagnostic drift. Laboratories change assays, reagents, or interpretive criteria without formal recalibration. This produces apparent changes in prevalence that reflect laboratory variation, not epidemiological change. Early detection requires blinded re-testing of archived samples whenever a laboratory changes its primary assay.

| Observation | Likely cause | Discriminating check |
|---|---|---|
| Divergent case counts across sectors | Different case definitions | Compare raw case data against each sector's definition |
| Apparent seasonal peak in one sector only | Sampling intensity varies by season | Plot sampling effort against detection counts |
| Wildlife detections cease after funding cuts | Surveillance activity discontinued | Verify sampling logs, also negative results |
| Prevalence shifts after laboratory change | Diagnostic drift | Re-test archived samples with the new assay |
| Delayed recognition of spillover | Wildlife component lost | Review wildlife sampling continuity and timeliness |

## Common Errors in Program Design

Less experienced program designers often treat all sectors as interchangeable data sources. They apply livestock sampling frames to wildlife populations, where capture probability varies by species, age, and habitat, and where the target population cannot be enumerated. The corrective action is to estimate detection probability for each species and to report surveillance sensitivity alongside raw prevalence.

A second error is over-reliance on a single diagnostic platform. The development of a protein A/G conjugate ELISA for Toxoplasma gondii detection across pigs, cats, mice, and seals demonstrates that multi-host serological tools are feasible, but it also shows that assay performance must be validated in each target species [Al-Adhami and Gajadhar, multi-host species indirect ELISA for Toxoplasma gondii](https://pubmed.ncbi.nlm.nih.gov/24365243/). A test validated in livestock cannot be assumed to perform identically in wildlife without species-specific validation.

A third error is confusing surveillance with control. Surveillance detects and monitors, control requires intervention authority, funding, and legal mandate. Programs that merge the two without clear governance structures tend to underperform at both. The distinction matters most for non-regulated diseases, where the purpose of the program, whether economic, welfare, or zoonotic risk reduction, determines the design and the instruments used [Nielsen et al., comparative review of Danish cattle surveillance programs](https://pubmed.ncbi.nlm.nih.gov/34350228/).

## Limitations of the Current Evidence

The evidence base for comparative surveillance is uneven. Livestock surveillance has the strongest quantitative literature because production data, movement records, and regulatory frameworks generate large datasets. Wildlife surveillance is comparatively weak, with few longitudinal studies and limited understanding of how host population structure affects pathogen maintenance and transmission. The vector competence studies for Usutu virus in German and Serbian Culex pipiens biotype molestus and Culex torrentium illustrate the value of experimental infection studies, but they also show how laboratory findings may not translate directly to field transmission, where mosquito abundance, host availability, and temperature interact [Holicki et al., vector competence of German and Serbian mosquitoes for Usutu virus](https://pubmed.ncbi.nlm.nih.gov/33380339/).

Expert opinion still differs on how much surveillance weight to place on wildlife. Some argue that wildlife surveillance should be prioritized because wildlife reservoirs drive emergence, while others contend that limited resources are better spent on livestock and human interfaces where interventions are more feasible. The mycobacterial diseases illustrate this tension: comprehensive animal surveillance programs have not achieved eradication in several industrialised countries, despite sustained investment [Rue-Albrecht et al., comparative functional genomics of the bovine macrophage response to mycobacteria](https://pubmed.ncbi.nlm.nih.gov/25414700/). Whether additional wildlife surveillance would change that outcome remains contested.

## Escalation and Referral Criteria

Referral to a specialist laboratory is warranted when a surveillance result is unexpected, when it has trade implications, or when it cannot be reproduced. Confirmatory testing should occur at a reference laboratory before any regulatory action is taken. For pathogens with human health significance, the relevant public health authority should be notified concurrently with the veterinary authority, since the human and animal surveillance systems serve complementary functions in tracking zoonoses such as avian influenza and foodborne pathogens [Kahn, confronting zoonoses linking human and veterinary medicine](https://pubmed.ncbi.nlm.nih.gov/16704801/).

Regulatory reporting is mandatory for diseases listed in the relevant international standards, and the reporting pathway differs by jurisdiction [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). Veterinarians should know which diseases are notifiable in their region and should report suspected cases even before laboratory confirmation. For non-listed diseases, reporting to a central surveillance database is voluntary but recommended, since aggregated data across sectors provides the only basis for detecting slow changes in disease distribution.

Specialist consultation is appropriate when a surveillance program is being designed or redesigned, when diagnostic test performance is uncertain in a new species, or when a cluster of cases spans multiple sectors without an obvious source. Epidemiologists, wildlife disease specialists, and public health veterinarians should be engaged early instead of after a program has failed. The international frameworks for One Health collaboration provide the institutional structure for such consultation [WHO One Health initiative](https://www.who.int/health-topics/one-health).

## Frequently Asked Questions

### How Do I Prioritize Which Zoonoses to Surveil When Resources Are Limited?

Prioritization requires a formal risk-ranking exercise that weighs human health impact, economic consequences, and feasibility of intervention. The [WHO One Health framework](https://www.who.int/health-topics/one-health) provides a structure for cross-sectoral engagement, while [CDC zoonotic disease resources](https://www.cdc.gov/one-health/index.html) offer practical guidance on prioritization methods. A defensible approach ranks pathogens by severity of human disease, transmissibility, availability of effective control measures, and cost of surveillance per case detected. Engage human health and wildlife authorities early so that criteria reflect all sectors. Document the ranking rationale explicitly. When a pathogen falls below the intervention threshold, state that decision and revisit it at defined intervals. Surveillance programs that attempt to monitor every zoonosis with equal intensity typically fail across all targets.

### What Surveillance Approach Works When Diagnostic Laboratory Capacity Is Limited?

Use syndromic surveillance and targeted risk-based sampling instead of pathogen confirmation for every case. Clinical case definitions agreed upon across sectors allow data collection before laboratory results return. For livestock, production records and mortality patterns often provide earlier signals than individual testing. For wildlife, pooled samples from hunter-harvested or found-dead animals can extend limited testing capacity. Serological assays that work across species, such as protein A/G conjugate ELISA formats described for Toxoplasma gondii detection, reduce the need for species-specific reagents and simplify laboratory workflows. Confirmatory testing can then be reserved for a subset of samples or for events that meet escalation criteria. Establish a triage protocol with the laboratory in advance so that scarce confirmatory capacity is allocated to the samples with the highest public health or trade significance.

### How Do Surveillance Objectives Differ Between Livestock-Dense Regions and Wildlife-Dominated Ecosystems?

Livestock-dense regions prioritize production-limiting pathogens and foodborne zoonoses, with surveillance often tied to trade certification and movement control. The Danish programs for bovine viral diarrhea and Salmonella Dublin illustrate how mandatory participation and legislative instruments drive eradication campaigns when economic and zoonotic motivations align. Wildlife-dominated ecosystems shift emphasis toward emerging pathogen detection and maintenance-host identification, where sampling is opportunistic and denominators are poorly defined. Vector-borne zoonoses such as Usutu virus require surveillance designs that integrate mosquito collections with wild bird mortality events and human case reports. The objectives determine the sampling frame, diagnostic tests, and decision thresholds. A program designed for a livestock-dense region cannot be transplanted to a wildlife setting without redefining its purpose, target population, and acceptable bias.

### What Records Must Be Kept to Make Cross-Sectoral Surveillance Data Defensible?

Records must document the sampling frame, selection method, diagnostic tests used, and the chain of custody for each sample. For livestock, individual animal identification and movement records are essential for traceability. For wildlife, record the species, location, date, and method of collection, plus any field observations relevant to interpretation. Laboratory records should include test protocol, quality control results, and the interpretive criteria applied. [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) specify documentation expectations for surveillance that supports international trade. Data sharing agreements between sectors must define who owns the data, who may access it, and how discrepancies are resolved. Retain raw data, also summaries, because re-analysis may be required when new information emerges about test performance or disease epidemiology.

### How Should I Explain Surveillance Findings to a Livestock Producer Who Fears Trade Consequences?

Lead with the producer's immediate concern, which is usually market access and herd health, then connect those concerns to the broader surveillance purpose. Explain that surveillance data can demonstrate freedom from disease and support continued trade, citing how [Danish Salmonella Dublin surveillance](https://pubmed.ncbi.nlm.nih.gov/34350228/) used mandatory participation and frequent legislative updates to reduce herd-level prevalence while maintaining market confidence. Be transparent about what a positive result does and does not mean, including the possibility of false positives and the confirmatory testing pathway. Provide the producer with a written summary of the findings, the next steps, and the expected timeline. Involve the herd veterinarian in the conversation whenever possible. Avoid guarantees about trade outcomes, since those decisions rest with regulatory authorities.

### When Should a Surveillance Finding Trigger Action Beyond the Routine Protocol?

Escalation is warranted when a pathogen appears in a new host species, a known zoonosis appears in a region where it was previously absent, or case numbers exceed the expected baseline by a predefined margin. [Comparative analysis of mycobacterial infections in cattle](https://pubmed.ncbi.nlm.nih.gov/25414700/) shows that even comprehensive surveillance programs can fail to eradicate pathogens, so sustained elevation despite control measures should prompt reassessment of the program design instead of simply intensified testing. Any finding with immediate human exposure risk, such as a foodborne pathogen detected in a product already in the distribution chain, requires urgent notification of public health authorities. Establish the escalation thresholds in writing before the program begins, and name the individuals authorized to declare an incident. Document every escalation decision and its rationale, since these records inform future threshold adjustments.

## Related Clinical & Scientific Guides

* [Wildlife Disease Surveillance: Designing and Implementing a One Health Program](/knowledge/veterinary-medicine/veterinary-public-health/wildlife-disease-surveillance-designing-implementing-one-health-program)
* [Biosecurity Risk Assessment for Livestock Operations: A Practical Framework](/knowledge/veterinary-medicine/veterinary-public-health/biosecurity-risk-assessment-livestock-operations-practical-framework)
* [Rabies Post-Exposure Prophylaxis in Veterinary Personnel](/knowledge/veterinary-medicine/veterinary-public-health/rabies-post-exposure-prophylaxis-in-veterinary-personnel)


## References and Further Reading

- [Confronting zoonoses, linking human and veterinary medicine.](https://pubmed.ncbi.nlm.nih.gov/16704801/). 2006.
- [Comparative macrolide use in humans and animals: should macrolides be moved off the World Health Organization's critically important antimicrobial list?](https://pubmed.ncbi.nlm.nih.gov/33956974/). 2021.
- [Comparative functional genomics and the bovine macrophage response to strains of the mycobacterium genus.](https://pubmed.ncbi.nlm.nih.gov/25414700/). 2014.
- [Narrative Review Comparing Principles and Instruments Used in Three Active Surveillance and Control Programs for Non-EU-regulated Diseases in the Danish Cattle Population.](https://pubmed.ncbi.nlm.nih.gov/34350228/). 2021.
- [German Culex pipiens biotype molestus and Culex torrentium are vector-competent for Usutu virus.](https://pubmed.ncbi.nlm.nih.gov/33380339/). 2020.
- [A new multi-host species indirect ELISA using protein A/G conjugate for detection of anti-Toxoplasma gondii IgG antibodies with comparison to ELISA-IgG, agglutination assay and Western blot.](https://pubmed.ncbi.nlm.nih.gov/24365243/). 2014.
- [WHO One Health Initiative](https://www.who.int/health-topics/one-health). WHO.
- [CDC One Health and Zoonotic Disease Resources](https://www.cdc.gov/one-health/index.html). CDC.
- [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual.

## Related Articles

- [Veterinary Public Health and Wildlife Trade: Risk Assessment](/knowledge/veterinary-medicine/veterinary-public-health/veterinary-public-health-and-wildlife-trade-risk-assessment)
- [Wildlife Disease Surveillance: Designing and Implementing a One Health Program](/knowledge/veterinary-medicine/veterinary-public-health/wildlife-disease-surveillance-designing-implementing-one-health-program)
- [Zoonotic Disease Surveillance in Animal Shelters: Methods and Challenges](/knowledge/veterinary-medicine/veterinary-public-health/zoonotic-disease-surveillance-in-animal-shelters-methods-and-challenges)
- [Wildlife Rehabilitation and Zoonotic Disease Risk: Protocols for Veterinary Professionals](/knowledge/veterinary-medicine/veterinary-public-health/wildlife-rehabilitation-zoonotic-disease-risk-protocols-veterinary-professionals)
- [Zoonotic Disease Management in Veterinary Practice: A One Health Framework](/knowledge/veterinary-medicine/veterinary-public-health/zoonotic-disease-management-veterinary-practice-one-health-framework)

> This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.